Prohibits money judgments arising from non-payment of facility items and services by a patient or patient guarantor that is brought by a facility; prohibits the enforcement of arbitration agreements or clauses with respect to non-payment of facility items and services by a patient or patient guarantor; relates to the collection of medical debt; requires transparency in hospital pricing.
S09711 would create a new hospital price transparency regime and add strong restrictions on how certain medical debts can be collected when they arise from facility items and services provided by hospitals or other covered facilities. The bill defines a "Hospital Price Transparency Act" in the Public Health Law and requires facilities to publicly post machine-readable and consumer-friendly lists of standard charges, including gross charges, negotiated rates, cash prices, billing codes, and shoppable-service pricing for at least 300 services or, if fewer are offered, all shoppable services the facility provides. It also requires annual updates, prominent website posting, and submission of updated lists to the Department of Health.
In addition to transparency requirements, the bill limits debt-collection and dispute-resolution practices for facilities that are in "material noncompliance" with the new pricing rules. It would bar money judgments in actions for nonpayment of facility items and services, prohibit enforcement of arbitration or mediation clauses in facility documents for those claims, and make it unlawful under the General Business Law for a noncompliant facility to refer the debt to collectors or report it to credit bureaus. Patients or guarantors could sue to determine whether a facility was materially noncompliant, and if a court finds noncompliance, the facility would have to refund third-party payers, pay the patient or guarantor an amount equal to the debt, dismiss collection actions with prejudice, pay attorney fees and costs, and remove related credit reporting.
The bill would amend the Civil Practice Law and Rules, the General Business Law, and the Public Health Law. It gives the Department of Health oversight authority to monitor compliance, review complaints, audit websites, require corrective action plans, publish facilities in material noncompliance, and impose daily civil penalties scaled to facility size. The act would take effect one year after becoming law.
Overall sentiment in the available record appears supportive of consumer protection and price transparency, but there is no committee transcript or voting history provided to show formal debate or opposition. The bill’s structure suggests a strong policy preference for limiting surprise billing, improving price disclosure, and reducing leverage in medical-debt collection when facilities fail to comply with transparency rules. Because no votes or hearing remarks are included, no direct sentiment from legislators or stakeholders can be confirmed from the record.
The main point of contention likely would be the bill’s enforcement mechanism: it ties a facility’s ability to sue, arbitrate, collect, and report debt to compliance with detailed transparency obligations, which could be viewed by hospitals as a significant operational and financial burden. Potential concerns may also include the breadth of the disclosure requirements, the administrative penalties, and the patient right to challenge collections actions. Supporters would likely emphasize consumer access to pricing information, accountability for hospitals, and relief from aggressive medical-debt collection practices.
The bill would substantially amend New York law by adding new Public Health Law section 2833 and by limiting debt-collection remedies under the Civil Practice Law and Rules and General Business Law for covered facilities that fail to comply with hospital price transparency requirements. It would regulate hospitals’ public disclosure of standard charges and shoppable-service pricing, and it would restrict lawsuits, arbitration, mediation, debt collection referrals, and credit reporting tied to nonpayment of facility charges when a facility is in material noncompliance. The Department of Health would gain new monitoring, enforcement, and penalty authority over covered facilities.
No committee transcript or vote record is provided, so formal legislative sentiment cannot be measured directly. Based on the bill text, the policy direction is clearly consumer-protective and transparency-focused, suggesting likely support from advocates of medical-debt reform and opposition or concern from hospitals and facility operators that would face new disclosure and enforcement obligations. The bill’s design indicates an intent to pressure compliance through financial and litigation consequences rather than voluntary reporting alone.
The most notable contention is likely between consumer advocates and hospital/facility operators over the bill’s enforcement model. Supporters would favor stronger price transparency, limits on surprise medical debt collection, and protections against arbitration and credit reporting when facilities fail to comply. Opponents may argue that the bill is overly punitive, that it could interfere with legitimate billing and collections, and that the detailed posting and reporting requirements are administratively burdensome. The linkage between transparency compliance and the ability to collect debts is especially significant and likely to be the central point of dispute.